Sentence and cancer type
Showing 361-380 of 577 items.
SentenceCancertype
Multiple endocrine neoplasia type 2B caused by a single point mutation in RET proto-oncogene in a Chinese patient. None
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. None
[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene]. None
RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A. None
Mutations of RET proto-oncogene may play an important role in the pathogenesis of Chinese patients with Hirschsprung disease.None
Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung s disease. None
A common haplotype at the 5 end of the RET proto-oncogene, overrepresented in Hirschsprung patients, is associated with reduced gene expression. None
A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients. None
Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases. None
Localization of the 5 end of the MCF2 oncogene to human chromosome 15q15----q23. None
An in vitro approach to test the possible role of candidate factors in the transcriptional regulation of the RET proto-oncogene. None
The RET/PTC1 oncogene activates a proinflammatory program, provide a direct link between a transforming human oncogene, inflammation, and malignant behavior.None
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. None
Detection of phosphorylated retTPC oncogene product in cytoplasm. None
Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene. None
Haplotypes of the human RET proto-oncogene associated with Hirschsprung disease in the Italian population derive from a single ancestral combination of alleles. None
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. None
BAY 43-9006 inhibition of oncogenic RET mutants. None
Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2. None
Mutation of RET proto-oncogene in Hirschsprung s disease and intestinal neuronal dysplasia. None